Stocks Overview

LAST PRICE
59.7700
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
59.7500/ 4
Ask / Lots
59.8700/ 4
Open / Previous Close
--- / 59.7700
Day Range
---
52 Week Range
Low 3.6000
High 59.9500
Volume
158
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 59.77
Time	Volume	LBPH
09:32 ET	4664	59.76
09:33 ET	13740	59.77
09:35 ET	6415	59.78
09:37 ET	10071	59.79
09:39 ET	10069	59.79
09:42 ET	14396	59.78
09:44 ET	200	59.78
09:46 ET	7126	59.765
09:48 ET	6567	59.77
09:50 ET	700	59.765
09:51 ET	5326	59.77
09:53 ET	6827	59.78
09:55 ET	7530	59.78
09:57 ET	10607	59.7701
10:00 ET	9098	59.775
10:02 ET	10277	59.78
10:04 ET	19222	59.78
10:06 ET	1967	59.78
10:08 ET	2878	59.78
10:09 ET	28343	59.769
10:11 ET	3875	59.76
10:13 ET	551	59.76
10:15 ET	14948	59.765
10:18 ET	9289	59.76
10:20 ET	2036	59.76
10:22 ET	17648	59.77
10:24 ET	3000	59.77
10:26 ET	9106	59.78
10:27 ET	5072	59.78
10:29 ET	2786	59.775
10:31 ET	19725	59.78
10:33 ET	17020	59.79
10:36 ET	13944	59.78
10:38 ET	5611	59.77
10:40 ET	3382	59.77
10:42 ET	7956	59.77
10:44 ET	12605	59.76
10:45 ET	3900	59.765
10:47 ET	4404	59.765
10:49 ET	1380	59.76
10:51 ET	1228	59.76
10:54 ET	1500	59.76
10:56 ET	1386	59.77
10:58 ET	12749	59.76
11:00 ET	7380	59.76
11:02 ET	1200	59.76
11:03 ET	6649	59.76
11:05 ET	1334	59.76
11:07 ET	12504	59.765
11:09 ET	10307	59.7793
11:12 ET	2952	59.775
11:14 ET	5670	59.77
11:16 ET	8742	59.78
11:18 ET	799	59.78
11:20 ET	1100	59.77
11:23 ET	400	59.775
11:25 ET	7039	59.775
11:27 ET	4827	59.77
11:30 ET	1800	59.77
11:32 ET	1300	59.77
11:34 ET	1757	59.765
11:36 ET	4972	59.765
11:38 ET	1824	59.765
11:39 ET	1153	59.76
11:41 ET	900	59.76
11:43 ET	1100	59.76
11:45 ET	2900	59.76
11:48 ET	1500	59.76
11:50 ET	4200	59.76
11:54 ET	700	59.76
11:56 ET	1965	59.765
11:57 ET	768	59.76
11:59 ET	3736	59.76
12:01 ET	2005	59.76
12:03 ET	900	59.765
12:06 ET	1459	59.76
12:08 ET	584	59.76
12:10 ET	1070	59.76
12:12 ET	1039	59.76
12:14 ET	51305	59.765
12:15 ET	1407	59.7698
12:19 ET	800	59.765
12:21 ET	100	59.76
12:24 ET	100	59.76
12:26 ET	400	59.76
12:28 ET	400	59.76
12:30 ET	1208	59.765
12:32 ET	900	59.76
12:33 ET	15356	59.765
12:35 ET	3920	59.76
12:37 ET	600	59.76
12:39 ET	600	59.765
12:42 ET	100	59.76
12:44 ET	10762	59.76
12:46 ET	200	59.765
12:48 ET	400	59.765
12:50 ET	2243	59.76
12:51 ET	7872	59.765
12:53 ET	6084	59.76
12:55 ET	600	59.76
12:57 ET	800	59.765
01:00 ET	1267	59.76
01:02 ET	4400	59.76
01:04 ET	4749	59.76
01:06 ET	1000	59.76
01:08 ET	21363	59.765
01:09 ET	10540	59.77
01:11 ET	100	59.76
01:13 ET	300	59.765
01:15 ET	500	59.76
01:18 ET	1354	59.765
01:20 ET	500	59.76
01:22 ET	1100	59.765
01:24 ET	800	59.765
01:26 ET	975	59.76
01:27 ET	600	59.76
01:29 ET	700	59.76
01:31 ET	800	59.76
01:33 ET	700	59.76
01:36 ET	700	59.76
01:38 ET	1207	59.765
01:40 ET	10808	59.765
01:42 ET	3376	59.76
01:44 ET	2065	59.765
01:45 ET	6477	59.765
01:47 ET	3237	59.765
01:49 ET	5408	59.765
01:51 ET	200	59.765
01:54 ET	1300	59.76
01:56 ET	10757	59.765
01:58 ET	16076	59.76
02:00 ET	846	59.76
02:02 ET	600	59.765
02:03 ET	1120	59.76
02:05 ET	300	59.765
02:07 ET	600	59.76
02:09 ET	700	59.765
02:12 ET	503	59.765
02:14 ET	726	59.76
02:16 ET	3999	59.765
02:18 ET	6522	59.765
02:20 ET	100	59.765
02:21 ET	500	59.76
02:23 ET	5505	59.765
02:25 ET	852	59.76
02:27 ET	400	59.765
02:30 ET	1598	59.76
02:32 ET	500	59.76
02:34 ET	500	59.76
02:36 ET	1531	59.765
02:38 ET	1347	59.76
02:39 ET	600	59.76
02:41 ET	1101	59.76
02:43 ET	1508	59.765
02:45 ET	889	59.76
02:48 ET	819	59.76
02:50 ET	1293	59.765
02:52 ET	17722	59.76
02:54 ET	3834	59.76
02:56 ET	1266	59.76
02:57 ET	440	59.76
02:59 ET	425	59.76
03:01 ET	1012	59.77
03:03 ET	5222	59.7698
03:06 ET	8755	59.76
03:08 ET	2053	59.765
03:10 ET	100	59.76
03:12 ET	1605	59.77
03:14 ET	800	59.765
03:15 ET	600	59.76
03:17 ET	271	59.77
03:19 ET	600	59.76
03:21 ET	2581	59.77
03:24 ET	600	59.765
03:26 ET	724	59.765
03:28 ET	1331	59.765
03:30 ET	900	59.765
03:32 ET	3202	59.765
03:33 ET	31793	59.775
03:37 ET	500	59.78
03:39 ET	1000	59.775
03:42 ET	100	59.77
03:44 ET	577	59.77
03:46 ET	804	59.77
03:48 ET	8451	59.78
03:50 ET	1105	59.77
03:51 ET	8119	59.775
03:53 ET	2968	59.77
03:55 ET	12679	59.77
03:57 ET	3401	59.77
04:00 ET	44100	59.77

Data delayed at least 15 minutes.

Nov 20, 2024
- SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MARX, BRKH, MNTX and LPBH, from 6:06PM ET on Wednesday Nov 20, 2024 by Dow Jones
  6:06PM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 12, 2024
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, LBPH, ZUO on Behalf of Shareholders, from 1:20PM ET on Tuesday Nov 12, 2024 by Dow Jones
  1:20PM ET on Tuesday Nov 12, 2024 by Dow Jones
- Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 7, 2024
- Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
- Press Release: Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:01PM ET on Thursday Nov 07, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesLBPH Longboard Pharmaceuticals Inc	2.3B	-26.7x	---
United StatesSLNO Soleno Therapeutics Inc	2.4B	-16.5x	---
United StatesCNTA Centessa Pharmaceuticals PLC	2.3B	-11.9x	---
United StatesGERN Geron Corp	2.4B	-12.5x	---
United StatesJANX Janux Therapeutics Inc	2.4B	-39.6x	---
United StatesKROS Keros Therapeutics Inc	2.2B	-10.3x	---
As of 2024-11-22

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. The Company is working to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). It is focused on developing various product candidates in its pipeline, which includes bexicaserin (LP352) and LP659. The Company plans to advance bexicaserin (LP352), an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with no observed impact on 5-HT2B and 5-HT2A receptor subtypes, into a global Phase 3 program. It is also evaluating LP659, an oral, centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, which is in development for the potential treatment of rare neuroinflammatory conditions. The Company is conducting a Phase 1 single-ascending dose (SAD) clinical trial for LP659 in healthy volunteers.

Contact Information

Headquarters: 4275 Executive Square, Suite 950LA JOLLA, CA, United States 92037
Phone: 619-592-9775
Fax: 302-636-5454

Executives

Independent Chairman of the Board: Paul Sekhri
President, Chief Executive Officer, Director: Kevin Lind
Chief Financial Officer, Executive Vice President: Brandi Roberts
Executive Vice President, Chief Medical Officer: Randall Kaye
Independent Director: Vincent Aurentz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$2.3B
Revenue (TTM)	$0.00
Shares Outstanding	39.0M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.05
EPS	$-2.24
Book Value	$1.67
P/E Ratio	-26.7x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Longboard Pharmaceuticals Inc
NASDAQ:LBPHUnited States

Search Criteria

Charts

Recent News

Nov 20, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MARX, BRKH, MNTX and LPBH, from 6:06PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 12, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, LBPH, ZUO on Behalf of Shareholders, from 1:20PM ET on Tuesday Nov 12, 2024 by Dow Jones

Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 7, 2024

Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones

Press Release: Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar